Data / Form D filings / SOFIE BIOSCIENCES, INC.
SOFIE BIOSCIENCES, INC.: Form D filings
SOFIE BIOSCIENCES, INC., a biotechnology company in Culver City, CA, filed 4 Form D notices with the SEC between 2013 and 2019. The latest, on July 29, 2019, reports $950,000 sold of a $950,000 offering to 14 investors.
Find out what SOFIE BIOSCIENCES, INC. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 6160 BRISTOL PARKWAY, Suite 200, Culver City, CA, 90230
- Phone
- (310) 242-6794
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1590830
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 29, 2019 | New notice | $950,000 | $950,000 | $0 | 14 | Jul 12, 2019 | sec.gov |
| Jun 6, 2017 | New notice | $16,752,250 | $0 | $16,752,250 | 0 | Yet to occur | sec.gov |
| Jun 13, 2016 | New notice | $4,000,004 | $3,700,000 | $300,004 | 9 | May 31, 2016 | sec.gov |
| Nov 4, 2013 | New notice | $5,000,004 | $5,000,004 | $0 | 12 | Sep 26, 2013 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Patrick E. Phelps | Executive Officer, Director | |
| Joel E. Cohen | Executive Officer | |
| Johannes E. Czernin | Director | |
| Ken E. Hermann, M.D. | Director | |
| James E. Heath | Director | |
| Michael E. Phelps | Director | |
| Ajit E. Singh | Director | |
| Howard E. Maron | Director | |
| Carl W. McKinzie | Director | |
| Philipp W. Czernin | Executive Officer | |
| Melissa W. Moore, Ph.D | Executive Officer |
Other biotechnology companies in California that filed recently
- CARI Health, Inc. $280,000 · Nov 6, 2026
- Ausel, Inc. $120,000 · Nov 4, 2026
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
Every Form D from the week of Jul 29, 2019 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what SOFIE BIOSCIENCES, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.